These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 22752867)

  • 21. Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?
    Lavan AH; McCartan DP; Downes MM; Hill AD; Fitzpatrick F
    Ir J Med Sci; 2012 Sep; 181(3):315-20. PubMed ID: 22350440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama.
    López-Ureña D; Quesada-Gómez C; Miranda E; Fonseca M; Rodríguez-Cavallini E
    J Med Microbiol; 2014 Feb; 63(Pt 2):322-324. PubMed ID: 24287669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.
    Kaltsas A; Simon M; Unruh LH; Son C; Wroblewski D; Musser KA; Sepkowitz K; Babady NE; Kamboj M
    J Clin Microbiol; 2012 Apr; 50(4):1303-7. PubMed ID: 22238444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of Clostridium difficile infection inside and outside health care institutions.
    Gerding DN; Lessa FC
    Infect Dis Clin North Am; 2015 Mar; 29(1):37-50. PubMed ID: 25582647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.
    Burnham CA; Carroll KC
    Clin Microbiol Rev; 2013 Jul; 26(3):604-30. PubMed ID: 23824374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile infections: do we know the real dimensions of the problem?
    Tattevin P; Buffet-Bataillon S; Donnio PY; Revest M; Michelet C
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S36-40. PubMed ID: 23664578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridioides difficile epidemiology in India.
    Monaghan TM; Biswas R; Satav A; Ambalkar S; Kashyap RS
    Anaerobe; 2022 Apr; 74():102517. PubMed ID: 35063600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
    Khanna S; Pardi DS
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
    Messick CA; Hammel JP; Hull T
    Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of first recurrence of Clostridium difficile infection: implications for initial management.
    Eyre DW; Walker AS; Wyllie D; Dingle KE; Griffiths D; Finney J; O'Connor L; Vaughan A; Crook DW; Wilcox MH; Peto TE;
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S77-87. PubMed ID: 22752869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
    Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
    Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Collins DA; Sohn KM; Wu Y; Ouchi K; Ishii Y; Elliott B; Riley TV; Tateda K;
    Emerg Microbes Infect; 2020; 9(1):42-52. PubMed ID: 31873046
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular epidemiology of
    Shoaei P; Shojaei H; Khorvash F; Hosseini SM; Ataei B; Tavakoli H; Jalali M; Weese JS
    Antimicrob Resist Infect Control; 2019; 8():12. PubMed ID: 30675339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile Infection in Children.
    Noor A; Krilov LR
    Pediatr Ann; 2018 Sep; 47(9):e359-e365. PubMed ID: 30208195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The continually evolving Clostridium difficile species.
    Cairns MD; Stabler RA; Shetty N; Wren BW
    Future Microbiol; 2012 Aug; 7(8):945-57. PubMed ID: 22913354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.
    Sofjan AK; Islam MA; Halder K; Kabir ND; Saleh AA; Miranda J; Lancaster C; Begum K; Alam MJ; Garey KW
    Anaerobe; 2020 Feb; 61():102081. PubMed ID: 31356958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Problems of
    Kiersnowska Z; Lemiech-Mirowska E; Ginter-Kramarczyk D; Kruszelnicka I; Michałkiewicz M; Marczak M
    Ann Agric Environ Med; 2021 Jun; 28(2):224-230. PubMed ID: 34184502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.